Skip to main content

Animations

MJFF Publications

1861 - 1870 of 6570 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2026
  • 2020
  • 2024
  • 2025
  • 2024
  • 2025
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70336
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson’s disease models
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1007/s00401-025-02956-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261421740
    Citation Count: 0
  • Summary Details
    OPEN
    Title: New 2013 incidence peak in childhood narcolepsy: more than vaccination?
    Journal Name: Sleep
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsaa172
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Interaction of PINK1 with nucleotides and kinetin
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adj7408
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A structural pathway for class III PI 3-kinase activation by the myristoylated GTP-binding pseudokinase VPS15
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.384
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A Novel Longitudinal Rank-Sum Test for Multiple Primary Endpoints in Clinical Trials: Applications to Neurodegenerative Disorders
    Journal Name: Statistics in Biopharmaceutical Research
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/19466315.2025.2458018
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
    Journal Name: Immunobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.imbio.2025.152892
    Citation Count: 5
  • Summary Details
    OPEN
    Title: α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106702
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.